RTEL1 has previously been identified as a risk factor for glioma, and studies have tried to identify whether telomere length has an established causative effect on the risk of glioma, although no definitive conclusion has been reached [9, 11, 18–20]. This evidence concerns the gene RTEL1 and central nervous system cancer.